These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 31383252)

  • 21. The LRRK2 G2385R variant is a partial loss-of-function mutation that affects synaptic vesicle trafficking through altered protein interactions.
    Carrion MDP; Marsicano S; Daniele F; Marte A; Pischedda F; Di Cairano E; Piovesana E; von Zweydorf F; Kremmer E; Gloeckner CJ; Onofri F; Perego C; Piccoli G
    Sci Rep; 2017 Jul; 7(1):5377. PubMed ID: 28710481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LRRK2 phosphorylation of auxilin mediates synaptic defects in dopaminergic neurons from patients with Parkinson's disease.
    Nguyen M; Krainc D
    Proc Natl Acad Sci U S A; 2018 May; 115(21):5576-5581. PubMed ID: 29735704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Role of LRRK2 in Intracellular Organelle Dynamics.
    Boecker CA
    J Mol Biol; 2023 Jun; 435(12):167998. PubMed ID: 36764357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LRRK2 and mitochondria: Recent advances and current views.
    Singh A; Zhi L; Zhang H
    Brain Res; 2019 Jan; 1702():96-104. PubMed ID: 29894679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of LRRK2 in cytoskeletal dynamics.
    Civiero L; Cogo S; Biosa A; Greggio E
    Biochem Soc Trans; 2018 Dec; 46(6):1653-1663. PubMed ID: 30467120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of lysosomal tubulation and sorting driven by LRRK2.
    Bonet-Ponce L; Kluss JH; Cookson MR
    Biochem Soc Trans; 2024 Aug; 52(4):1909-1919. PubMed ID: 39083004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LRRK2 recruitment, activity, and function in organelles.
    Bonet-Ponce L; Cookson MR
    FEBS J; 2022 Nov; 289(22):6871-6890. PubMed ID: 34196120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LRRK2 activation in idiopathic Parkinson's disease.
    Di Maio R; Hoffman EK; Rocha EM; Keeney MT; Sanders LH; De Miranda BR; Zharikov A; Van Laar A; Stepan AF; Lanz TA; Kofler JK; Burton EA; Alessi DR; Hastings TG; Greenamyre JT
    Sci Transl Med; 2018 Jul; 10(451):. PubMed ID: 30045977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leucine-Rich Repeat Kinase (LRRK2) Genetics and Parkinson's Disease.
    Monfrini E; Di Fonzo A
    Adv Neurobiol; 2017; 14():3-30. PubMed ID: 28353276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitochondrial Calcium Dysregulation Contributes to Dendrite Degeneration Mediated by PD/LBD-Associated LRRK2 Mutants.
    Verma M; Callio J; Otero PA; Sekler I; Wills ZP; Chu CT
    J Neurosci; 2017 Nov; 37(46):11151-11165. PubMed ID: 29038245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LRRK2 along the Golgi and lysosome connection: a jamming situation.
    Piccoli G; Volta M
    Biochem Soc Trans; 2021 Nov; 49(5):2063-2072. PubMed ID: 34495322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synaptic, Mitochondrial, and Lysosomal Dysfunction in Parkinson's Disease.
    Nguyen M; Wong YC; Ysselstein D; Severino A; Krainc D
    Trends Neurosci; 2019 Feb; 42(2):140-149. PubMed ID: 30509690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular effects mediated by pathogenic LRRK2: homing in on Rab-mediated processes.
    Madero-Pérez J; Fdez E; Fernández B; Lara Ordóñez AJ; Blanca Ramírez M; Romo Lozano M; Rivero-Ríos P; Hilfiker S
    Biochem Soc Trans; 2017 Feb; 45(1):147-154. PubMed ID: 28202668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LRRK2 and Autophagy.
    Manzoni C; Lewis PA
    Adv Neurobiol; 2017; 14():89-105. PubMed ID: 28353280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dysregulated phosphorylation of Rab GTPases by LRRK2 induces neurodegeneration.
    Jeong GR; Jang EH; Bae JR; Jun S; Kang HC; Park CH; Shin JH; Yamamoto Y; Tanaka-Yamamoto K; Dawson VL; Dawson TM; Hur EM; Lee BD
    Mol Neurodegener; 2018 Feb; 13(1):8. PubMed ID: 29439717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The unconventional G-protein cycle of LRRK2 and Roco proteins.
    Terheyden S; Nederveen-Schippers LM; Kortholt A
    Biochem Soc Trans; 2016 Dec; 44(6):1611-1616. PubMed ID: 27913669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How Parkinson's Disease-Linked LRRK2 Mutations Affect Different CNS Cell Types.
    Bailey HM; Cookson MR
    J Parkinsons Dis; 2024; 14(7):1331-1352. PubMed ID: 38905056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LRRK2 and idiopathic Parkinson's disease.
    Rocha EM; Keeney MT; Di Maio R; De Miranda BR; Greenamyre JT
    Trends Neurosci; 2022 Mar; 45(3):224-236. PubMed ID: 34991886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leucine-rich repeat kinase 2 phosphorylation on synapsin I regulates glutamate release at pre-synaptic sites.
    Marte A; Russo I; Rebosio C; Valente P; Belluzzi E; Pischedda F; Montani C; Lavarello C; Petretto A; Fedele E; Baldelli P; Benfenati F; Piccoli G; Greggio E; Onofri F
    J Neurochem; 2019 Aug; 150(3):264-281. PubMed ID: 31148170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Upshot of LRRK2 Inhibition to Parkinson's Disease Paradigm.
    Esteves AR; G-Fernandes M; Santos D; Januário C; Cardoso SM
    Mol Neurobiol; 2015 Dec; 52(3):1804-1820. PubMed ID: 25394383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.